TCA
BMRN icon

Troluce Capital Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Troluce Capital Advisors’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Hold
0
– – – 21
2024
Q4 		– Hold
0
– – – 23
2024
Q3 		– Sell
-71,600
Closed -$5.89M – 52
2024
Q2 		$5.89M Buy
+71,600
New +$5.89M 0.58% 22